These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27062520)

  • 1. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
    Wu X; Cai S; Li Z; Zheng C; Xue X; Zeng J; Peng J
    Virol J; 2016 Apr; 13():64. PubMed ID: 27062520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
    Law ST; Lee MK; Lee AS; Tung Y; Li KK
    J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
    BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: a meta-analysis.
    Su QM; Ye XG
    World J Gastroenterol; 2012 Nov; 18(43):6290-301. PubMed ID: 23180951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
    J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy.
    Liu B; Shen B; Mei M; Li L; Wang X; Zhao H
    Ther Apher Dial; 2020 Feb; 24(1):56-63. PubMed ID: 31090170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
    Cai S; Cao J; Yu T; Xia M; Peng J
    Medicine (Baltimore); 2017 Jun; 96(22):e7021. PubMed ID: 28562554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis.
    Shen H; Ding F; Wang Z; Sun F; Yu Y; Zhou J; Xu W; Ni J; Wang J; Yang Y
    Cell Physiol Biochem; 2016; 40(1-2):370-378. PubMed ID: 27866195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
    Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
    Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
    Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
    Pan HY; Pan HY; Song WY; Zheng W; Tong YX; Yang DH; Dai YN; Chen MJ; Wang MS; Huang YC; Zhang JJ; Huang HJ
    J Viral Hepat; 2017 Nov; 24 Suppl 1():29-35. PubMed ID: 29082652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification.
    Choi JW; Kim SH; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Lee YK; Lee CK
    Yonsei Med J; 2018 May; 59(3):383-388. PubMed ID: 29611400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH; Choi JW; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Shin SY; Lee CK
    Yonsei Med J; 2017 May; 58(3):552-556. PubMed ID: 28332360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
    Li W; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis.
    Lee HY; Oh H; Park CH; Yeo YH; Nguyen MH; Jun DW
    World J Gastroenterol; 2019 Jun; 25(23):2961-2972. PubMed ID: 31249453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of telbivudine and entecavir against virus reactivation in HBeAg-patients undergoing chemotherapy.
    Chen CJ; Yu HC; Chang CW; Bair MJ; Lin CC; Lin YS; Cai ZS; Chen MJ
    Medicine (Baltimore); 2020 May; 99(22):e20330. PubMed ID: 32481407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
    Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.